How the pandemic set back drug safety

Manipulating data, destroying documents, altering staff training records, retesting samples and only recording those that pass – drug companies have been caught doing all these things.

The only thing stopping them: the element of surprise in the hands of strong regulators. The regulators may still be vigilant, but the pandemic put the brakes on unannounced inspections. Restoring them could save lives.